teplizumab-mzwv
Drug Details
- Generic Name
- teplizumab-mzwv
- Brand Names
- TZIELD
- Application Number
- BLA761183
- Sponsor
- Provention Bio, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- TEPLIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE TZIELD is indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients 1 year of age and older with Stage 2 type 1 diabetes [see Dosage and Administration (2.1) ] . TZIELD is a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients 1 year of age and older with Stage 2 T1D ( 1 ).